Pharmacopsychiatry

Papers
(The TQCC of Pharmacopsychiatry is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels126
Review and Consensus on Pharmacogenomic Testing in Psychiatry105
The History of Psychedelics in Psychiatry70
Classic Psychedelic Drugs: Update on Biological Mechanisms41
Psychedelics and Psychotherapy37
Classical Psychedelics as Therapeutics in Psychiatry – Current Clinical Evidence and Potential Therapeutic Mechanisms in Substance Use and Mood Disorders34
Classic Psychedelic Coadministration with Lithium, but Not Lamotrigine, is Associated with Seizures: An Analysis of Online Psychedelic Experience Reports32
Candidate Psychotropics against SARS – CoV – 2: A Narrative Review23
Opportunities for Drug Repurposing of Serotonin Reuptake Inhibitors: Potential Uses in Inflammation, Infection, Cancer, Neuroprotection, and Alzheimer’s Disease16
Novel Antidepressants in the Pipeline (Phase II and III): A Systematic Review of the US Clinical Trials Registry16
The Potential Role of Psychedelic Drugs in Mental Health Care of the Future15
Serious Adverse Drug Reactions in Children and Adolescents Treated On- and Off-Label with Antidepressants and Antipsychotics in Clinical Practice15
Neurotrophic Properties of Silexan, an Essential Oil from the Flowers of Lavender-Preclinical Evidence for Antidepressant-Like Properties15
Opioid Mortality Following Implementation of Medical Cannabis Programs in the United States15
Novel Long-Acting Buprenorphine Medications for Opioid Dependence: Current Update14
Drug-drug Interactions between COVID-19 Treatments and Antidepressants, Mood Stabilizers/Anticonvulsants, and Benzodiazepines: Integrated Evidence from 3 Databases13
Effects of Pharmacokinetic Gene Variation on Therapeutic Drug Levels and Antidepressant Treatment Response13
Neuropsychiatric Drugs Against COVID-19: What is the Clinical Evidence?12
COVID-19: Risks, Complications, and Monitoring in Patients on Clozapine12
Pharmacological Treatment of Early-Onset Schizophrenia: A Critical Review, Evidence-Based Clinical Guidance and Unmet Needs11
Pharmacological Treatment of Schizophrenia: Japanese Expert Consensus10
Endocannabinoid Modulation Using Monoacylglycerol Lipase Inhibition in Tourette Syndrome: A Phase 1 Randomized, Placebo-Controlled Study10
Linkage of Young Mania Rating Scale to Clinical Global Impression Scale to Enhance Utility in Clinical Practice and Research Trials10
Dexmedetomidine in Psychiatry: Repurposing of its Fast-Acting Anxiolytic, Analgesic and Sleep Modulating Properties10
Baseline Working Memory Predicted Response to Low-Dose Ketamine Infusion in Patients with Treatment-Resistant Depression9
Systematic Review and Meta-Analysis of L-Methylfolate Augmentation in Depressive Disorders9
Effect of Quetiapine, from Low to High Dose, on Weight and Metabolic Traits: Results from a Prospective Cohort Study9
Anti-SARS-CoV-2 Action of Fluvoxamine may be Mediated by Endothelial Nitric Oxide Synthase8
Metformin Attenuates the Metabolic Disturbance and Depression-like Behaviors Induced by Corticosterone and Mediates the Glucose Metabolism Pathway8
Expression Biomarkers of Pharmacological Treatment Outcomes in Women with Unipolar and Bipolar Depression8
Impact of Psychiatric and Related Somatic Medications on the Duration and Severity of COVID-19: A Retrospective Explorative Multi-center Study from the German M7
Sex-specific Association of Antipsychotic-induced Weight Gain and Treatment Response for Antipsychotic-Naive First Episode Schizophrenia Patients: A Prospective 8-week Longitudinal Study6
Psychedelics: A New Treatment Paradigm in Psychiatry?6
Dose-Corrected Serum Concentrations and Metabolite to Parent Compound Ratios of Venlafaxine and Risperidone from Childhood to Old Age6
Cannabinoids in the Treatment of Selected Mental Illnesses: Practical Approach and Overview of the Literature5
Clinical Outcomes after Clozapine Discontinuation in Patients with Schizophrenia: A Systematic Review5
Digital Phenotyping and Mobile Sensing in Addiction Psychiatry5
Frequencies of Genetic Polymorphisms of Clinically Relevant Gene-Drug Pairs in a German Psychiatric Inpatient Population5
Factors Associated with Medication Adherence to Long-Acting Injectable Antipsychotics: Results from the STAR Network Depot Study5
Association between Adherence to SSRI Treatment and Mortality among Individuals with Metabolic Syndrome Components5
0.036370038986206